Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

News
Patients With Acne Receive Unsolicited Advice, Want More Information From Providers
01/31/2021
In a survey administered to patients with acne, the vast majority of respondents reported receiving unsolicited advice from others, but they also indicated that they were dissatisfied with information from their...
In a survey administered to patients with acne, the vast majority of respondents reported receiving unsolicited advice from others, but they also indicated that they were dissatisfied with information from their...
In a...
01/31/2021
The Dermatologist
Trivia of the Day: Response to Therapy in Psoriatic Arthritis
Quiz
Trivia of the Day: Response to Therapy in Psoriatic Arthritis
01/30/2021
At the end of the 52-week study period, approximately how many patients achieved American College of Rheumatology (ACR) criteria for 20% improvement in their signs and symptoms of psoriatic arthritis after receiving the 100-mg Q12W dosing of...
At the end of the 52-week study period, approximately how many patients achieved American College of Rheumatology (ACR) criteria for 20% improvement in their signs and symptoms of psoriatic arthritis after receiving the 100-mg Q12W dosing of...
At the end of the 52-week study...
01/30/2021
The Dermatologist
Wound Healing 101: Updates from Dr Kirsner
Conference Coverage
Wound Healing 101: Updates from Dr Kirsner
01/29/2021
In his yearly update on the latest in wound healing at the Maui Derm conference, Robert S. Kirsner, MD, PhD, offered several useful pearls for dermatologists to bring into their practice immediately.
In his yearly update on the latest in wound healing at the Maui Derm conference, Robert S. Kirsner, MD, PhD, offered several useful pearls for dermatologists to bring into their practice immediately.
In his yearly update on the...
01/29/2021
The Dermatologist
Challenging Cases, Featuring Tips From the Psoriasis Experts
Conference Coverage
Challenging Cases, Featuring Tips From the Psoriasis Experts
01/28/2021
In a 2-hour digital workshop at Maui Derm Connect, four psoriasis experts highlighted treatment strategies in various challenging cases of the papulosquamous disease.
In a 2-hour digital workshop at Maui Derm Connect, four psoriasis experts highlighted treatment strategies in various challenging cases of the papulosquamous disease.
In a 2-hour digital workshop at...
01/28/2021
The Dermatologist
Patients on Their Psoriatic Disease: Results From the UPLIFT Survey
Conference Coverage
Patients on Their Psoriatic Disease: Results From the UPLIFT Survey
01/28/2021
A survey of patients with psoriatic disease found many respondents reported that their current disease, clinically considered to have limited skin involvement, was moderate to severe in severity. The results of the survey were published as a...
A survey of patients with psoriatic disease found many respondents reported that their current disease, clinically considered to have limited skin involvement, was moderate to severe in severity. The results of the survey were published as a...
A survey of patients with...
01/28/2021
The Dermatologist
Trivia of the Day: Long-term Maintenance of Response in Psoriasis
Quiz
Trivia of the Day: Long-term Maintenance of Response in Psoriasis
01/28/2021
Of the patients who received a 100-mg dose of tildrakizumab and achieved PASI 100 at 52 weeks in the reSURFACE 2 trial, how many maintained this level of response at the end of the trial extension?
Of the patients who received a 100-mg dose of tildrakizumab and achieved PASI 100 at 52 weeks in the reSURFACE 2 trial, how many maintained this level of response at the end of the trial extension?
Of the patients who received a...
01/28/2021
The Dermatologist
The Burden of Molluscum Contagiosum: A Caregiver Survey
Conference Coverage
The Burden of Molluscum Contagiosum: A Caregiver Survey
01/28/2021
Molluscum contagiosum causes a significant impact on the quality of life of caregivers and on the activities of their children with MC, according to a poster presented at Maui Derm Connect 2021.
Molluscum contagiosum causes a significant impact on the quality of life of caregivers and on the activities of their children with MC, according to a poster presented at Maui Derm Connect 2021.
Molluscum contagiosum causes a...
01/28/2021
The Dermatologist
Trends in Generalized Pustular Psoriasis: What Your Peers are Prescribing
Conference Coverage
Trends in Generalized Pustular Psoriasis: What Your Peers are Prescribing
01/28/2021
According to a survey of derms by Strober et al, the clinical manifestations of skin symptoms are the driving factor in the selection of treatment options for GPP. The results and analysis of the survey were presented at Maui Derm Connect...
According to a survey of derms by Strober et al, the clinical manifestations of skin symptoms are the driving factor in the selection of treatment options for GPP. The results and analysis of the survey were presented at Maui Derm Connect...
According to a survey of derms...
01/28/2021
The Dermatologist
Real-World Data on Dose Escalation of Biologics
Conference Coverage
Real-World Data on Dose Escalation of Biologics
01/28/2021
According to a poster abstract by Wu et al presented at Maui Derm Connect 2021, dose escalation was significantly lower with one IL-23 inhibitor vs all other available biologics for the treatment of moderate to severe plaque psoriasis.
According to a poster abstract by Wu et al presented at Maui Derm Connect 2021, dose escalation was significantly lower with one IL-23 inhibitor vs all other available biologics for the treatment of moderate to severe plaque psoriasis.
According to a poster abstract...
01/28/2021
The Dermatologist
Trivia of the Day: Metabolic Syndrome and Safety
Quiz
Trivia of the Day: Metabolic Syndrome and Safety
01/28/2021
In their poster presented at Maui Derm Connect, Fernandez et al found patients with metabolic syndrome who received tildrakizumab 100 mg were more likely to develop the treatment-emergent adverse events over a 5-year period.
In their poster presented at Maui Derm Connect, Fernandez et al found patients with metabolic syndrome who received tildrakizumab 100 mg were more likely to develop the treatment-emergent adverse events over a 5-year period.
In their poster presented at...
01/28/2021
The Dermatologist
Photoprotection for Visible Light: Do We Need It?
Conference Coverage
Photoprotection for Visible Light: Do We Need It?
01/27/2021
Think about it: have your patients asked about the dangers of blue light? How about skin damage from cell phones or computer screens? Curtis Cole, PhD, answered these questions and more in his presentation at Maui Derm Connect.
Think about it: have your patients asked about the dangers of blue light? How about skin damage from cell phones or computer screens? Curtis Cole, PhD, answered these questions and more in his presentation at Maui Derm Connect.
Think about it: have your...
01/27/2021
The Dermatologist
Trivia of the Day: Tildrakizumab and Mature Patients
Quiz
Trivia of the Day: Tildrakizumab and Mature Patients
01/27/2021
In a post hoc pooled analysis, what conclusion did Van de Kerkhof et al reach regarding the safety of tildrakizumab in patients aged 65 years and older?
In a post hoc pooled analysis, what conclusion did Van de Kerkhof et al reach regarding the safety of tildrakizumab in patients aged 65 years and older?
In a post hoc pooled analysis,...
01/27/2021
The Dermatologist
Pediatric Psoriasis Pearls and Updates
Conference Coverage
Pediatric Psoriasis Pearls and Updates
01/27/2021
As part of the “Pediatric Dermatology 2021” session, Dr Lawrence Eichnfield discussed a number of pearls regarding pediatric psoriasis.
As part of the “Pediatric Dermatology 2021” session, Dr Lawrence Eichnfield discussed a number of pearls regarding pediatric psoriasis.
As part of the “Pediatric...
01/27/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Volume 32 - Issue 6 - September 2024

Current Issue

September 2024
Volume 32
Issue 6
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Cover Story
Navigating Women’s Health Dermatology Through Life’s Stages
09/06/2024
By addressing specific needs at each stage, dermatologists can provide comprehensive and empathetic care, enhancing both the health and confidence of their patients.
By addressing specific needs at each stage, dermatologists can provide comprehensive and empathetic care, enhancing both the health and confidence of their patients.
By addressing specific needs at...
09/06/2024
The Dermatologist
NEA Approved Features
Perspectives in Atopic Dermatitis
05/08/2023
Coleen Stern, MA, Senior Managing Editor
We highlight takeaways that will transform the way you care for this patient population.
We highlight takeaways that will transform the way you care for this patient population.
We highlight takeaways that will...
05/08/2023
The Dermatologist
Case Report and Brief Review
Drug-Induced Acne and Acneiform Eruptions: A Review
08/13/2009
Although less common than other subtypes of the condition, dermatologists need to consider drug-induced acne or acneiform types of folliculitis in their diagnoses.
Although less common than other subtypes of the condition, dermatologists need to consider drug-induced acne or acneiform types of folliculitis in their diagnoses.
Although less common than other...
08/13/2009
The Dermatologist
Research in Review
What Is Causing The Rash On This Woman's Inner Elbow?
01/13/2017
David L. Kaplan, MD
This 28-year-old woman presented with a 2-month history of a rash that was confined to her right antecubital fossa and that had a burning sensation.
This 28-year-old woman presented with a 2-month history of a rash that was confined to her right antecubital fossa and that had a burning sensation.
This 28-year-old woman presented...
01/13/2017
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Trivia of the Day: Response to Therapy in Psoriatic Arthritis
Quiz
Trivia of the Day: Response to Therapy in Psoriatic Arthritis
01/30/2021
At the end of the 52-week study period, approximately how many patients achieved American College of Rheumatology (ACR) criteria for 20% improvement in their signs and symptoms of psoriatic arthritis after receiving the 100-mg Q12W dosing of...
At the end of the 52-week study period, approximately how many patients achieved American College of Rheumatology (ACR) criteria for 20% improvement in their signs and symptoms of psoriatic arthritis after receiving the 100-mg Q12W dosing of...
At the end of the 52-week study...
01/30/2021
The Dermatologist
Trivia of the Day: Long-term Maintenance of Response in Psoriasis
Quiz
Trivia of the Day: Long-term Maintenance of Response in Psoriasis
01/28/2021
Of the patients who received a 100-mg dose of tildrakizumab and achieved PASI 100 at 52 weeks in the reSURFACE 2 trial, how many maintained this level of response at the end of the trial extension?
Of the patients who received a 100-mg dose of tildrakizumab and achieved PASI 100 at 52 weeks in the reSURFACE 2 trial, how many maintained this level of response at the end of the trial extension?
Of the patients who received a...
01/28/2021
The Dermatologist
Trivia of the Day: Metabolic Syndrome and Safety
Quiz
Trivia of the Day: Metabolic Syndrome and Safety
01/28/2021
In their poster presented at Maui Derm Connect, Fernandez et al found patients with metabolic syndrome who received tildrakizumab 100 mg were more likely to develop the treatment-emergent adverse events over a 5-year period.
In their poster presented at Maui Derm Connect, Fernandez et al found patients with metabolic syndrome who received tildrakizumab 100 mg were more likely to develop the treatment-emergent adverse events over a 5-year period.
In their poster presented at...
01/28/2021
The Dermatologist
Trivia of the Day: Tildrakizumab and Mature Patients
Quiz
Trivia of the Day: Tildrakizumab and Mature Patients
01/27/2021
In a post hoc pooled analysis, what conclusion did Van de Kerkhof et al reach regarding the safety of tildrakizumab in patients aged 65 years and older?
In a post hoc pooled analysis, what conclusion did Van de Kerkhof et al reach regarding the safety of tildrakizumab in patients aged 65 years and older?
In a post hoc pooled analysis,...
01/27/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement